Gene Query: TMEM159

Dataset Description Geneva Score
RNA-seq in untreated and flagellin-treated Human Intestinal Myofibroblast cells (HIMF) 39.03
Defining a microRNA-mRNA targetome for calcineurin inhibitor induced nephrotoxicity 26.19
AZ1366: An inhibitor of tankyrase and the canonical Wnt pathway that limits the persistence of non-small cell lung cancer cells following EGFR inhibition 23.64
Transcriptional profiling identifies differential expression of long non-coding RNAs in Jo-1 associated and inclusion body myositis 20.84
Identifying lincRNA as prognostic biomarker for clear cell renal cell carcinoma 20.67
Gene expression in skeletal muscle in older individuals subject to ten days of complete bed rest. 19.52
Disruption of the exocyst induces podocyte loss and dysfunction 18.49
Exercise-induced transcriptome changes in skeletal muscle adapted to aerobic training 17.89
Role of CD133 molecule in WNT response and renal repair 17.54
Global epigenomic reconfiguration during mammalian brain development 16.63
Myeloid-derived suppressor cells facilitie invasion and metastasis of papillary thyroid cancer cells by repressing miR-486-3p 15.68
LINE-1 elements are derepressed in senescent cells and elicit a chronic Type-I Interferon response 14.81
Genome-wide expression profiling of an in vitro model for studying esophageal epithelial differentiation 14.27
RNA-Seq profiling of iPSC-derived ventricular and atrial cardiomyocytes 14.03
siRNA-mediated silencing of ORAI3 in MDA-MB-468 breast cancer cells exposed to hypoxia 13.87
MicroRNA (miR)-211 loss promotes metabolic vulnerability and BRAF inhibitor sensitivity in melanoma 13.64
The E3 ubiquitin ligase HectD1 suppresses EMT and metastasis by targeting the +TIP protein ACF7 for degradation 13.53
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors [RNA-seq] 13.04
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors 13.04
Insights into snoRNA biogenesis and processing from PAR-CLIP of snoRNA core proteins and small RNA sequencing 13.02
Molecular pathogenesis of human prostate basal cell hyperplasia reveals a keratinocyte metaplasia 12.89
Region-specific Innate Antiviral Responses of the Human Epididymis 12.83
Analysis and expansion of the eosinophilic esophagitis transcriptome by RNA sequencing 12.36
Expression by CD133+ cells isolated from the adult human exocrine pancreas 12.3
The DNM3OS lncRNA is a reservoir of fibromiRs with major functions in fibroblast response to TGF-beta and fibrogenesis 12.21
RNA-Seq analysis of human lung fibroblasts exposed to TGF-β 12.21
RNA-Seq analysis and comparison of corneal epithelium in keratoconus and myopia patients 12.18
Genome-wide expression change by SHARPIN knockdown in MCF-7 cells 12.14
Expression data from human perivascular stem cell-derived extracellular vesicles (PSC-EVs) and PSCs 11.82
mRNA and RNC-mRNA deep sequencing of three hepatocellular carcinoma cell lines 11.81
A pooled single-cell genetic screen identifies regulatory barriers in the continuum of the epithelial-to-mesenchymal transition 11.34
Effect of selective glucocorticoid receptor modulation (SGRM) on gene expression in human prostate cancer cell lines 11.11
Diffuse Large B Cell Lymphoma cell line with Acquired Resistance to PI3Kδ Inhibitor Idelalisib 10.78
Transcripotome analysis of different locations of hair follicles (bulb, bulge) in androgenetic alopecia 10.34
Induction of human hemogenesis in adult fibroblasts by defined factors and hematopoietic co-culture 10.13
TGFβ-induced fibroblast activation requires persistent and targeted HDAC-mediated gene repression 10.0
Effect of hypoxia and TGFβ1 on gene expression in HPF fibroblast cells 9.86
Gene expression profile in response to HIF-1α inhibition together with PPARα activation and the postnatal factors (T3, IGF-1 and dexamethasone) in hiPSC-CMs 9.83
RNA-Seq analysis of primary human keratinocytes exposed to Cannabidiol 9.49
RNA-seq of human fibroblasts after irradiation 9.38
Histone demethylase LSD1 is required for germinal center formation and BCL6 driven lymphomagenesis 9.1
Transcriptional changes in lymphoma cells induced by LSD1 depletion 9.1
Genistein and bisphenol A exposure cause estrogen receptor 1 to bind thousands of binding sites in a cell type-specific manner 9.09
RNA-sequencing of pediatric idiopathic dilated cardiomyopathy patients and healthy controls 9.06
Gene expression in PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition. 9.05
PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition 9.05
Urinary sediment transcriptomic and longitudinal data to investigate renal function decline in type 1 diabetes 8.93
Tamoxifen Resistance in Breast Cancer is Regulated by the EZH2-ERa-GREB1 Transcriptional Axis 8.79
A SRp55-regulated alternative splicing network controls pancreatic beta cell survival and function 8.48
Identifying the molecular mode of action of itraconazole in colorectal cancer 8.37
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation [RNA-Seq] 8.25
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation 8.25
Transcriptomic and gene ontology profiling of the human corneal cell types 8.24
Global transcriptional profiling changes upon knockdown of LKB1 in human glioblastoma cell lines 8.16
mRNA Sequencing of Human PromoCells Using Random Primed mRNA-Sequencing Technique 7.91
Genome expression analysis of Lung Progenitors matured in the presence of constitutively active or pharmacologically inhibited Glycogen Synthase Kinase 3 7.87
Analysis of transcrptomes of Danon patient derived hiPSC-cardiomyocytes by RNA-deep Sequencing 7.76
Effects of a nutritional supplement in older individuals subject to ten days of complete bed rest. 7.64
RNA-Seq of human induced pluripotent stem cell-derived cardiomyocytes from a cardiomyopathy patient and familial control 7.48
PGE2 mediated gene expression changes in human cervical stromal cells 7.46
Subclonal cooperation drives metastasis through modulating local and systemic immune microenvironments 7.45
Transcriptome analysis of ECFCs treated with GSK-343 and Panobinostat 7.43
Mitochondrial phosphoenolpyruvate carboxykinase (PCK2) regulates metabolic adaptation and glucose-independent tumor cell growth 7.41
A cell cycle-based functional screen to identify lncRNA-based cancer biomarkers 7.31
Rational targeting of RNA structure in SMN2 transcripts reverses Spinal Muscular Atrophy molecular phenotypes 7.27
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L 7.05
RNA-Sequencing shows novel transcriptomic signatures in failing and non-failing human heart 6.82
Transcriptomes analysis for the regulation of Z36 induced autophagy in HeLa cell death 6.57
Race-specific transcriptome and Long non-coding RNA of ADT-resistant African-American prostate cancer cell models. 6.55
Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging 6.52
RNA-seq of YB5 cells treated with Proscillaridin A 6.45
RNA-sequencing time course of Human Intestinal Epithelial Cells (HIECs) following knockdown of miR-30bcd using complementary locked nucleic acids 6.34
Valproic acid attenuates hyperglycemia induced complement and coagulation cascade gene expression 6.31
Functional Screening in Human Cardiac Organoids Reveals a Metabolic Mechanism for Cardiomyocyte Maturation 6.15
ARID1A is a critical regulator of luminal identity and therapeutic response in oestrogen receptor-positive breast cancer (RNA-Seq) 6.15
Transcriptome analysis of BAP1 knockout and restoration 6.12
Expression profiles of restoration of BAP1 in a BAP1 deficient cell line 6.12
Epigenome regulation during epidermal lineage commitment [RNA-seq] 6.03
Suppression of NAF-1 in Breast Cancer Cells Reduces their Tumorigenicity by Interfering with Cellular Iron Distribution and Metabolism and Ensuing ROS Formation and Apoptosis 5.99
Transcriptomic analysis of the effect of trastuzumab in human iPSC-CMs 5.9
The impact of pro-inflammatory cytokines on the β-cell regulatory landscape provides insights into the genetics of type 1 diabetes 5.9
RNA-seq differential expression studies: more sequence, or more replication? 5.89
Functional interactions between Mi-2β and AP1 complexes control response and recovery from barrier disruption 5.78
Supraphysiological Androgens Repress Prostate Cancer Growth and Induce DNA Damage Augmented by PARP Inhibition 5.78
Apatinib preferentially inhibits Gefitinib-resistant lung cancer cells by inducing cell cycle arrest and inhibiting VEGFR signaling pathway 5.76
Comparison of expression profiles of APP-depleted prostate cancer cells (LNCaP) 5.76
Differential gene expression of static and intermittent compressive force treated human periodontal ligament cells 5.65
RNA-Seq of Kaposi’s sarcoma reveal alterations in glucose and lipid metabolism 5.64
The Human Testis Cell Atlas via Single-cell RNA-seq 5.63
Sequencing-based analyses characterize a tumor suppressive role of mir-1271 repressed by DNA hypermethylation in gastric cancer 5.58
Induction of extracellular adenosine salvage and metabolic quiescence regulate the transitional to follicular B cell checkpoint in humans. 5.55
mRNA sequencing analysis of cultured human primary airway epithelial cells upon exposure to PMN exosomes 5.47
Global transcriptional analysis and genome-wide analysis of chromatin state in extended pluripotent stem cells, primed pluripotent stem cells, and naïve pluripotent stem cells 5.46
Global transcriptional analysis of human extended pluripotent stem cells, human primed pluripotent stem cells, mouse extended pluripotent stem cells, and mouse embryonic stem cells by RNA-seq 5.46
Integration of genome-wide DNA methylome and transcriptome of human intestinal fibroblasts reveals novel candidate gene signatures in Crohn’s disease-associated fibrosis 5.41
Simultaneous profiling of sexually transmitted bacterial pathogens, microbiome, and concordant host response in cervical samples using whole transcriptome sequencing analysis 5.3
Long non-coding RNA TYKRIL controls pericyte function and survival in the cardiovascular and central nervous system through regulation of p53 activity and PDGFRß expression 5.24
MeRIP-seq for heat shock in B-cell lymphoma cells 5.21
Interaction with WDR5 recruits MYC to a small cohort of genes required for tumor onset and maintenance 5.14
Pervasive transcription read-through promotes aberrant expression of oncogenes and RNA chimeras in renal carcinoma 5.11
Effect of mitochondria deficiency on senescence-associated gene expression 5.06
An integrative network biology analysis identifies miR-508-3p as the determinant and a prognosis biomarker of the mesenchymal subtype ovarian cancer 5.0
Generating Patterned Kidney Organoids for Studying Development and Diseases 4.98
Identification of PRMT5-dependent genes in ESA+CD24lowCD44+ MCF7 cells 4.98
The antineoplastic drug, trastuzumab, dysregulates metabolism in iPSC derived cardiomyocytes. 4.92
Propargite, an environmental chemical, interacts with GWAS identified diabetes genes to impact human pancreatic β-cell death 4.91
A potent and selective small-molecule degrader of STAT3 achieves complete tumor regression in vivo 4.91
Stem cell and neurogenic gene-expression profiles link prostate basal cells to aggressive prostate cancer 4.9
RNA sequencing to compare gene expession in control and PF228-treated hepatic stellate cells 4.87
Reprogramming of Tumor-infiltrating Immune Cells in Early Stage of NSCLC 4.86
Gene expression profile in breast cancer cell lines using RNA sequencing 4.86
A common cell state in Triple Negative Breast Cancers represents a druggable vulnerability 4.83
RNA-Seq study of Cell lines rendered resistant to idelalisib and ibrutinib 4.82
Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer 4.78
Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer [RNA-Seq] 4.78
Simultaneous quantification of antibody-RNA conjugates and the transcriptome from fixed cells by RAID 4.77
Effect of nuclear IL-33 on gene expression 4.75
Paxillin regulates genomic networks in prostate cancer [LNCaP] 4.73
FOXD3 is a novel tumor suppressor in lung cancer 4.71
BAF controls genome accessibility 4.63
Single cell analysis of HSV-1 infection reveals anti-viral and developmental programs are activated in distinct sub-populations with opposite outcomes 4.58
RNAseq of PRMT4KD in human cord blood derived CD34+ cells 4.57
Differential gene expression in Jagged1 treated human dental pulp cells. 4.57
Dermal fibroblasts play a central role in skin model protection against C. albicans invasion 4.51
RNASEQ Analysis of sh-TRC and sh-MIR100HG in the triplex negative breast cancer 4.45
Non-coding regions are the main source of tumor-specific antigens [human] 4.41
Non-coding regions are the main source of tumor-specific antigens 4.41
Expression level comparison under dividing and quiescent states in human primary fibroblasts 4.38
Forkhead domain mutations in FOXA1 drive prostate cancer cell progression 4.28
RNA-seq in LNCaP cell line overexpressing WT or mutant FOXA1 4.28
Human induced pluripotent stem cell-derived vocal fold mucosa mimics development and responses to smoke exposure 4.25
Food-derived Compounds Apigenin and Luteolin Modulate mRNA Splicing of Introns with Weak Splice Sites 4.25
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer (RNA-Seq) 4.18
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer 4.18
Modeling Human Cancer-induced Cachexia (Human) 4.16
High-throughput sequencing of the human hepatic progenitor cell niche in PSC and HCV. 4.12
Genome-wide analysis of STAT3 in diffuse large B-cell lymphoma 4.12
Genome wide transcript and miRNAanalysis of invitro and in-vivo generated human cardiac samples 4.11
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation [RNA-Seq] 4.11
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation 4.11
Transcriptome wide analysis of translation efficiency in MCF7 cells using polysome profiling with and without eIF4A inhibition by hippuristanol treatment 4.1
Identification of elevated A-to-I editing sites due to expression of an active ADAR3 mutant in human glioblastoma cells 4.06
RNA-sequencing of isogenic primary, pre-malignant immortalized, and Ras-transformed human mammary epithelial cells 4.05
Heterogeneous effects of massive hypoxia pathway activation in kidney cancer 4.04
Novel mutations segregating with Complete Androgen Insensitivity Syndrome and their molecular characteristics. 4.02
Transcriptional landscape changes during human embryonic stem cell derivation 4.0
LncRNA NMR knockdown and overexpression in esophageal squamous cell carcinoma cell lines 3.99
Long Non-coding RNA PICSAR Promotes Growth of Cutaneous Squamous Cell Carcinoma by Regulating ERK1/2 Activity 3.98
Genomic Reorganization of Lamin-Associated Domains in Cardiac Myocytes is Associated with Differential Gene Expression and DNA Methylation in Human Dilated Cardiomyopathy [RNA-Seq] 3.94
Genomic Reorganization of Lamin-Associated Domains in Cardiac Myocytes is Associated with Differential Gene Expression and DNA Methylation in Human Dilated Cardiomyopathy 3.94
mRNA Sequencing of Human PromoCells Using 3'-directed Digital Gene Expression (3'-DGE) Technique 3.93
Inhibition of ERG Activity in Patient Derived Prostate Cancer Xenografts using the Small Molecule Inhibitor YK-4-279 3.9
Next-generation RNA sequencing to determine changes in gene expression during breast cancer progression 3.88
Transcriptome analysis of U87 cells upon LINC00152 knockdown 3.86
Transcriptional changes in pancreatic cancer cells associated with gemcitabine resistance 3.81
A large panel of isogenic APP and PSEN1 mutant human iPSC neurons reveals shared endosomal abnormalities mediated by APP b-CTFs, not Ab [RNA-seq] 3.81
Control of gene expression in senescence through transcriptional read-through of convergent protein-coding genes 3.79
Transcriptome analysis of virus infected tissues 3.77
RNA-seq data from human SGBS adipocytes differentiated with marine oxohexadecenoic acids 3.77
Developing a Novel Two-Dimensional Culture System to Enrich Human Prostate Luminal Progenitors That Can Function as a Cell of Origin for Prostate Cancer 3.77
Transcriptome of human white and brown adipose tissue biopsies 3.77
Comparing oestrogen-responsive genes in endometrial and breast cancer cell lines 3.76
Transcriptome sequencing of differentially expressed genes in acne inversa (AI) patients with NCSTN mutation and healthy individuals 3.75
Transcriptome sequencing of differentially expressed genes in mouse and human skin with and without NCSTN mutation 3.75
Repurposing of promoters and enhancers during mammalian evolution 3.72
Effect of PRDM11 depletion in U2932 cells 3.72
Transcriptome analysis of PC9 cells with gefitinib or/and hypoxia treatment and comparison with gefitinib resistant PC9 cells and ALDH positive PC9 cells 3.72
Incomplete MyoD-induced transdifferentiation is mediated by chromatin remodeling deficiencies [RNA-Seq] 3.71
Incomplete MyoD-induced transdifferentiation is mediated by chromatin remodeling deficiencies 3.71
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression [RNA-seq] 3.67
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression 3.67
Candidate genes and pathways downstream of PAX8 involved in ovarian high-grade serous carcinoma 3.66
Combined inhibition of STAT3 and DNA repair in palbociclib-resistant ER-positive breast cancer 3.66
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator [RNA-seq] 3.64
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator 3.64
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming 3.64
Tumor exosome integrins determine organotropic metastasis 3.63
The effect of Foxc1 deficiency on undifferentiated and differentiated human primary keratinocytes 3.6
Brain organoids reproducibly generate the cellular diversity of the human cerebral cortex 3.56
RNA-seq analysis reveals endogenous aryl hydrocarbon receptor regulation is highly associated with eicosanoid synthesis and tumor necrosis factor activity in MCF-7 cancer cells 3.55
RNA-Seq comparisons of gene expression profiles of epithelial and mesenchymal cells - HMLE, N8, N8-CTx 3.52
ChIP-seq and RNA-Seq analyses of epithelial and mesenchymal cells - HMLE, N8, N8-CTx 3.52
RNA-sequencing experiment: Treatment of MCF-7 breast cancer cells with the novel small molecule ZNA 3.45
Tumor suppressor SMARCB1 suppresses super-enhancers to govern hESC lineage determination 3.45
Efficient direct reprogramming of c-Kit− mature amniotic cells into endothelial cells by ETS factors and TGFβ suppression 3.43
RNA deep sequencing analysis of human brain microvascular endothelial cells (ECs) treated with glioma-conditioned medium (glioma-CM) 3.4
NOTCH signaling is activated in and contributes to resistance in enzalutamide-resistant prostate cancer cells 3.38
CSL 3.38
CSL RNA-Seq on HKC and SCC cell lines 3.38
Epigenomic landscape during organ formation in human early embryos 3.35
A global identification of PUM1 and PUM2 mRNA targets and their protein cofactors in human seminoma TCam-2 cells 3.33
Transcriptome analysis reveals malignant and hypoxic signature of glioblastoma 3.33
Histone acetyltransferase p300 induces de novo super-enhancers to drive cellular senescence 3.28
Histone acetyltransferase p300 induces de novo super-enhancers to drive cellular senescence [RNA-seq] 3.28
IRF2 is a master regulator of human keratinocyte stem cell fate [RNA-seq] 3.28
IRF2 is a master regulator of human keratinocyte stem cell fate 3.28
Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq B-ALL) 3.27
GREB1 amplifies androgen receptor output in prostate cancer and contributes to antiandrogen resistance 3.25
Transcriptomic analysis of iPSC and ESC challenged with atmospheric or physiological oxygen 3.22
APOBEC mutation drives early-onset squamous cell carcinomas in recessive dystrophic epidermolysis bullosa 3.2
Global modulation of signaling pathways by SARM RAD140 in AR/ER+ breast cancer xenografts 3.2
MUC1-C Drives Lineage Plasticity in Progression to Neuroendocrine Prostate Cancer 3.18
The RNA binding protein IGF2BP3 promotes hematopoietic progenitor cell proliferation by targeting leukemogenic pathways 3.17
Gene expression analysis of airway epithelial cells exposed to flagellin via RNA-seq and microarray 3.16
Gene expression analysis of airway epithelial cells exposed to flagellin via RNA-seq 3.16
Improving fibroblast characterization using single-cell RNA sequencing: an optimized tissue disaggregation and data processing pipeline 3.14
Global gene expression differences between blood- and lymphatic-specific endothelial colony forming cells 3.12
Disrupted prenatal RNA processing and myogenesis in congenital myotonic dystrophy 3.1
Single-cell RNA-Seq Investigation of Foveal and Peripheral Expression in the Human Retina 3.1
Neurofibromin is an Estrogen Receptor alpha Transcriptional Co-repressor in Breast cancer 3.09
RNA-seq of IL-4 stimulated human keratinocytes 3.04
Identification of Atrial Fibrillation associated genes and functional non-coding variants 3.02
IGF2BP3 controls cancer cell invasiveness by modulation RISC function 3.01
RNA sequencing of Asthmatic Human Airway Smooth Muscle Cells II 3.0
Transcriptomic alterations in fibroblasts from Parkinson's disease patients carrying Parkin mutations 3.0
A single cell reference map for human blood and tissue T cell activation 2.99
Single cell RNA-seq resolves lineage-specific activation dynamics of human blood and tissue T cells 2.98
Transcriptomic characterization of a human in vitro model of arrhythmogenic cardiomyopathy under topological and mechanical stimuli 2.96
CHD1 regulates cell fate determination by activation of differentiation-induced genes 2.94
Prostaglandin E2 inhibits pro-fibrotic function of human pulmonary fibroblasts by disrupting Ca2+-signaling 2.92
Genome-wide maps in MCF-7 cells with six2 or CYP4Z1 3'UTR or CYP4Z2P 3'UTR overexpression or not 2.92
PR isoform-specific ER and PR chromatin binding and gene expression observed in-vitro in breast cancer cells. 2.9
Transcriptome Sequencing of Adipose-Derived Mesechymal Stromal Cells 2.9
HNF1 regulates critical functions of the human epididymis epithelium. [RNA-Seq] 2.89
HNF1 regulates critical functions of the human epididymis epithelium. 2.89
IL-33 activates tumor stroma to promote intestinal polyposis 2.89
RNA-sequencing of mRNAs from control and CAP-D3 deficient Salmonella infected HT-29 cells 2.88
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells (wtRNA-Seq) 2.87
SLIGRL-induced gene expression changes in NHEK cells 2.86
RNA-seq identifies novel lncRNAs involved in vascular smooth muscle cell proliferation 2.84
Thymine DNA Glycosylase as a novel target for melanoma: effect of TDG silencing on gene expression in SK-mel-28 melanoma cells 2.83
A transcriptome dataset revealing the molecular features of breast cancer stem cells 2.82
The Promyelocytic Leukemia Zinc Finger Dependent Transcriptome during Human Endometrial Stromal Cell Decidualization 2.82
Human iPSC derived glomeruli facilitate accurate modelling of podocytopathy 2.81
DNA Methylation Reprograms Metabolic Gene Expression in End-Stage Human Heart Failure 2.81
Inhibition of Enhancer of Zeste Homologue 2 attenuates TGF-β dependent hepatic stellate cell activation and liver fibrosis 2.81
Xeno-free and Chemically Defined Human System for Culturing Human Epidermal Keratinocytes 2.81
LncRNA NONHSAT113026 represses renal cell carcinoma tumorigenesis through interacting with NF-κB/p50 and SLUG 2.79
Splicing towards noncoding isoforms in colorectal carcinoma is associated with tumor hypoxia and the DNA damage response 2.78
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression 2.76
RAID allows multiplexed quantification of intracellular (phospho-)proteins and transcriptomes from fixed single cells 2.76
Dual role of CSL (RBP-Jk) and NOTCH1 in CAF 2.76
Dual role of CSL (RBP-Jk) and NOTCH1 in cancer-associated fibroblast genome stability and expansion [RNA-seq] 2.76
DHX15 regulates CMTR1-dependent gene expression and cell proliferation 2.75
RNA-seq analysis of human cardiosphere cells with different tubule supportive potential 2.74
Azithromycin induces epidermal differentiation and multivesicular bodies in airway epithelia 2.72
Endothelial gene expression analysis 2.72
Total RNA deep sequencing (ribosomal depleted) of human umbilical vein endothelial cells exposed to hypoxia (0.2%) for 12h and 24h or kept under normoxic conditions. 2.72
Gene expression analysis of immortalized human liver progenitor-like cells in culture 2.71
Trans-chromosomal regulation by a novel lincRNA required for adipogenesis that escapes X-chromosome inactivation 2.71
Platelet Transcriptome Profiling in HIV and ABCC4 as a Biomarker of Platelet Activity 2.71
HNF1A deficiency impairs β-cell fate, granule maturation and function 2.71
H1609088 Human RNA-Sequencing 2.69
Genome wide expression change in LCC2 and MCF-7 cells 2.69
Next generation sequencing of human hepatic stellate cell line, LX-2 treated with recombinant human TGF-β1, with DMSO or ML290 (5 µM) for 72h. 2.69
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs with in vivo activity in hematological malignancies [RNA-Seq] 2.67
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs with in vivo activity in hematological malignancies 2.67
Expression profile of HNF1A knockdown and overexpression in 22RV1 and LNCaP cells respectively 2.67
Integrin signaling regulates YAP/TAZ to control skin homeostasis 2.65
C9orf72 Intermediate Repeats are Associated with Corticobasal Degeneration, Increased C9orf72 Expression and Disruption of Autophagy 2.63
Gene expression data from IMR90 control, IMR90 shRRM2 and shRRM2/shp16 2.62
Integrative transcriptome-wide analyses reveal critical HER2-regulated mRNAs and lincRNAs in HER2+ breast cancer 2.62
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells [RNA-seq] 2.6
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells 2.6
The influence of PPFIA1 silencing to gene expression in breast carcinoma cell line and head and neck squamous cell carcinoma cell lines by RNA-sequencing in three dimensional collagen I 2.6
The effect of insulin on mRNA transcription of human pluripotent stem cells 2.57
Novel Form of JARID2 is Required to Regulate Differentiation in Keratinocytes. 2.56
A comparison of gene expression between lesional and non-lesional derived keratinocytes of Hailey-Hailey disease patients. 2.55
In vivo genome editing restores dystrophin expression in Duchenne muscular dystrophy patient muscle fibers 2.54
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition [CAGE] 2.5
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition 2.5
Differential Gene Expression between MCF10A and MCF7 cells 2.48
RNAseq of IL-36 stimulated primary human keratinocytes 2.47
Illumina HiSeq Sequencing on Breast cancer PDX samples 2.47
mRNA-sequencing of U87 glioblastoma and DAOY medulloblastoma spheroidal aggregates undergoing electrotaxis 2.46
RNA deep sequencing to compare genome-wide differences between PRMT5/knockdown and control AML cells 2.45
Identifying deer antler proliferation and mineralization genes using comparative RNA-seq 2.45
Estrogen Receptor Beta Impacts Hormone-Induced Alternative mRNA Splicing in Breast Cancer Cells 2.44
SIRT7 Antagonizes TGF-β Signaling and Inhibits Breast Cancer Metastasis 2.43
Splicing function of mitotic regulators links R-loop mediated DNA damage to tumor cell killing 2.42
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence [RNA-Seq] 2.41
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence 2.41
Effects of Spaceflight on Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Structure and Function 2.39
Identifying a novel candidate diagnostic and prognostic biomarker SPRR3 for oral squamous cell carcinoma via mRNA Sequencing and Bioinformatics 2.38
CDK4/6 inhibitor resistance in prostate cancer 2.38
RNA-sequencing of fibrolamellar carcinoma (FLC) cell line treated with miR-375 mimic 2.36
Epigenetic Control of Skeletal Development by the Histone Methyltransferase Ezh2 2.35
Single-cell RNA-seq reveals novel cell differentiation dynamics during human airway epithelium regeneration 2.33
Wnt addiction of genetically defined cancers reversed by PORCN inhibition 2.33
RNA Sequencing of Human iPS derived Cardiomyocytes 2.33
Gene expression profiling study by RNA-seq in PDX model based diffuse type gastric cancers. 2.32
Illumina sequencing of vaginal epithelial cells from women using depot medroxyprogesterone acetate or non-hormonal contraception 2.3
RNA-seq of MCF10A cells and CAF 2.27
Synectin Promotes Fibrogenesis by Regulating PDGFR Isoforms Through Distinct Mechanisms 2.26
mRNA-sequencing of breast cancer subtypes and normal tissue 2.26
Transcriptomics profiles of patient-matched normal kidney and ccRCC pairs 2.21
RNA-seq of stable and unstable section of human atherosclerotic plaques 2.2
T47D xenografts treated with various combinations of ER- and PR-targeting therapies 2.2
Human Induced Pluripotent Stem Cells Recapitulate Breast Cancer Patients’ Predilection to Doxorubicin-Induced Cardiotoxicity 2.18
Global analysis of enhancer targets: Mosaic-seq 2.17
Bulk RNA-sequencing of cell types isolated by FACS from normal human prostates 2.16
Identification of an IL-1-induced gene expression pattern in AR+ PCa cells that mimics the molecular phenotype of AR- PCa cells 2.16
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection 2.15
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection [RNA-seq] 2.15
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer 2.15
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer [RNA-Seq] 2.15
Epigenome regulation during epidermal lineage commitment 2.14
Modulation of mitochondrial DNA copy number to induce hepatocytic differentiation of human Amniotic Epithelial cells 2.14
Translocation of dense granule effectors across the parasitophorous vacuole membrane in Toxoplasma-infected cells requires the activity of ROP17, a rhoptry protein kinase 2.09
Transcriptome changes due to nuclear penetration of cancer extracellular vesicles 2.08
Reprogrammed myeloid cell transcriptomes in NSCLC 2.07
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers 2.06
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers (RNA-Seq) 2.06
Identification of a Cell-of-Origin for Fibroblasts Comprising the Fibrotic Reticulum in Idiopathic Pulmonary Fibrosis 2.04
Multiple waves of transcriptome changes during extended hypoxic induction in human pulmonary microvascular endothelial cells 2.01
Human-specific gene ARHGAP11B promotes basal progenitor amplification and neocortex expansion 2.0
Discovery of a Drug Candidate for GLIS3-Associated Diabetes 1.97
Differentially Expressed Genes for Atrial Fibrillation Identified using RNA Sequencing from Paired Human Left and Right Atrial Appendages. 1.95
In Vivo Chemical Screen Nominates Valproic Acid as Pharmacologic Modulator of Hematopoietic Stem and Progenitor Cell Activity 1.93
Splicing and gene expression changes in human mammary epithelial MCF-10A cells expressing SR or SR-like proteins 1.92
RNA editing in nascent RNA affects pre-mRNA splicing 1.9
Modeling genome-wide transcriptional cis-regulation in n LNCaP-abl cell line after siRNA knock down of a series of gene factors [RNA-seq] 1.87
RNA isoform screens reveal the essentiality and tumor suppressor activity of ultraconserved poison exons 1.87
Gene expression analysis of ER+ and ER- breast cancer cell lines with acquired resistance to palbociclib 1.86
Dissecting cell composition and cell-cell interaction network of human disease heart tissue by single-cell sequencing 1.85
Effect of REST on cancer invasiveness in MCF-7 and MDA-MB-231 cells using RNA-sequencing (RNA-seq) analysis . 1.84
Priming mobilization of hair follicle stem cells triggers permanent loss of regeneration after alkylating chemotherapy 1.83
p63 controls the enhancer landscape during keratinocyte differentiation 1.81
Transcriptional profiling of MDA-MB-231 and its ρ0 cells (lacking mtDNA) after 48h arginine depletion by arginine deiminase (ADI). 1.77
Intrinsic histone acetyltransferase activity of BRD4 is responsible for nucleosome eviction and transcriptional activation 1.77
Paclitaxel plus Cirmtuzumab Achieves Greater Clearance of Patient-derived Xenografts By Targeting ROR1+ Breast Cancer Stem Cells 1.77
Promoter of lncRNA gene *PVT1* is a tumor suppressor DNA element 1.76
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and PVT1 Knockdown by CRISPRi in MDA-MB-231 human breast cancer cell line 1.76
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 1.75
Splicing and epigenetic factors jointly regulate epidermal differentiation 1.75
Selective expression of long non-coding RNAs in a breast cancer cell progression model 1.72
Single-cell analysis of adult human ovary using 10X genomics 1.72
FBP2 inhibits sarcoma progression by restraining mitochondrial biogenesis 1.72
A Hybrid Mechanism of Action for BCL6 in B Cells Defined by Formation of Functionally Distinct Complexes at Enhancers and Promoters 1.71
LIN28A modulates splicing and gene expression programs in breast cancer cells 1.7
LIN28A modulates splicing and gene expression programs in breast cancer cells [RNA-Seq] 1.7
Epigenetic alterations affecting transcription factors and signaling pathways in stromal cells of endometriosis 1.69
Epigenetic alterations affecting transcription factors and signaling pathways in stromal cells of endometriosis: Expression data (RNA-seq) 1.69
Gene expression profiling of iPSC-derived cardiomyocytes with BAG3 mutations 1.68
RNA-sequencing of tamoxifen-resistant and -sensitive breast cancer cell lines. 1.68
BMS-470539 on human synovial fibroblasts 1.67
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells 1.65
RNA-sequencing transcriptome profiling of normal human keratinocytes differentiation 1.59
RNA-seq and flow-cytometry of conventional, scalp, and palmoplantar psoriasis reveal shared and distinct molecular pathways 1.59
Transcriptional profiling at the DLK1/MEG3 domain explains clinical overlap between imprinting disorders 1.58
RNA-seq data 1.58
Morphological and molecular characterization of human dermal lymphatic collectors 1.52
Gene expression profiling via RNA sequencing of patient brain tumors cultured in 3D bioengineered cultures 1.52
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells (mRNA-Seq) 1.52
Activating PAX Gene Family Paralogs to Complement PAX5 Leukemia Driver Mutations 1.5
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer [RNA-Seq] 1.49
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer 1.49
Exploring the gene expression profile upon FXR1 knockdown in H358 cells using RNA-seq 1.48
Dissecting cell composition and cell-cell interaction network of normal human heart tissue by single-cell sequencing 1.46
RNA-seq characterization of downstream effects of upregulating SMN2 via down-regulating PRC2 or blocking the PRC2:SMN-AS1 interaction with a mixmer oligonucleotide 1.45
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [BAV] 1.44
Conversion of Human Gastric Epithelial Cells to Multipotent Endodermal Progenitors using Defined Small Molecules [gene expression] 1.43
Conversion of Human Gastric Epithelial Cells to Multipotent Endodermal Progenitors using Defined Small Molecules 1.43
Defective transcription elongation in a subset of cancers confers immunotherapy resistance (BGI12 RNA-Seq) 1.42
Transcriptome sequencing after MAGOHB knockdown in MAGOH-deleted or non-deleted cancer cells 1.41
Group A Streptococcus M1T1 Intracellular Infection of Primary Tonsil Epithelial Cells Dampens Levels of Secreted IL-8 Through the Action of SpyCEP 1.41
The transition from proliferation to quiescence in glioblastoma stem-like cells requires Ca2+ signaling and mitochondria remodeling 1.4
Single cell transcriptome of peritoneal cells 1.39
Histone H3.1K27 methylation promotes NHEJ by antagonizing FANCD2 on Chromatin 1.38
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth [RNA-Seq] 1.36
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth 1.36
Combinatorial Reprogramming of Estrogen Signaling by the Nuclear Receptor Family 3C 1.33
BioProject PRJNA381064: Convergent origination of a Drosophila-like dosage compensation mechanism in a reptile lineage (Gene expression profiling in several tetrapod species, bulk tissue RNA-seq) 1.33
Joint-specific DNA transcriptome signatures in rheumatoid arthritis [RNA-seq] 1.33
Transcriptomic analysis of senescent cells upon EXOC7 knockdown. 1.31
Molecular characterization of gene regulatory networks in primary human tracheal and bronchial epithelial cells. 1.29
Identification of altered developmental pathways in human juvenile HD iPSC with 71Q and 109Q using transcriptome profiling 1.29
Acetyl-CoA carboxylase inhibition regulates microtubule dynamics and intracellular transport in cystic fibrosis epithelial cells 1.26
Acquisition of a hybrid E/M state is essential for tumorigenicity of basal breast cancer cells 1.26
Translating transcriptome of cancer cells in situ in mesenchymal-rich tumor microenvironment 1.25
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq Cell lines] 1.25
Studying the selectivity of a targeted small molecule degrading a hypoxia-associated non-coding RNA 1.23
A transcriptional regulatory network connects mitochondrial biogenesis and metabolic shift with stem cell commitment to hepatic differentiation 1.22
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling (RNA-seq) 1.2
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling 1.2
MALT1 Inhibition Is Efficacious in Both Naïve and Ibrutinib-Resistant Chronic Lymphocytic Leukemia. 1.2
Functional Comparison of the HGF/Met and MSP/Ron Systems in a Pancreatic Cancer Model 1.18
RNA-seq, ChIP-seq and single cell RNA-seq of human skin Langerhans cells 1.18
A genomic study of the contribution of DNA methylation to regulatory evolution in primates 1.18
The phosphatidylinositol 3-kinase pathway as a potential therapeutic target in bladder cancer 1.17
GRHL2 is a key lineage determining factor which collaborates with FOXA1 to establish a targetable collateral pathway in the setting of endocrine therapy-resistant breast cancer (RNA-Seq data set 1) 1.17
TALEN-based knockout of mir-141 and mir-200c in SK-BR-3 cells 1.15
Gene expression changes due to PARP knockdown in human cells 1.13
Interaction between mitoNEET and NAF-1 in cancer cells 1.1
MRTF activates TEAD-YAP target gene expression 1.09
Single-Cell reconstruction of differentiation trajectory reveals essential dynamics in human cardiac lineage commitment 1.07
Next generation sequencing of the transcriptome in MCF-7 cells with/without SRA knockdown 1.06
Effect of SF3B1 suppression in cancer cells with different SF3B1 copy-number levels 1.05
The circadian transcriptional landscape in primary human mammary epithelial cells 1.02
Persistence of stem cell metabolism in cancers as a failure of differentiation 1.02
Dilated cardiomyopathy vs Myocarditis 1.0
Transcriptome Analysis and Functional Identification of Adipose-Derived Mesenchymal Stem Cells in Secondary Lymphedema 1.0
Transcriptome of invasive mucinous adnocarcinoma of the lung and adjacent normal lung tissues from 6 patients based on RNA-seq method 0.98
Effect of OVO-like 1 knockdown on global transcript expression in differentiated BeWo trophoblast cells 0.94
Cooperative and Antagonistic Transcriptional Regulation by BRG/BRM [RNA-seq] 0.93
Co-regulation of transcription by BRG1 and Brm, two mutually exclusive SWI/SNF ATPase subunits 0.93
Exploiting Prmt5-orchestrated intron detention signatures to treat splicing-addicted malignant glioma tumors 0.92
Ribosome Incorporation into Somatic Cells Promotes Lineage Transdifferentiation towards Multipotency [RNA-Seq] 0.91
Ribosome Incorporation into Somatic Cells Promotes Lineage Transdifferentiation towards Multipotency 0.91
RNASeq of Healthy Human Skin Tregs and CD4 Teffs versus Psoriatic Human Skin Tregs and CD4 Teffs 0.9
Genome-wide modelling of transcription kinetics reveals patterns of RNA processing delays 0.87
Identification of miRNA-mRNA regulatory network for Human Atrial Aging 0.86
Identification of miRNA-mRNA regulatory network for Human Atrial Aging [mRNA] 0.86
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) II 0.86
Single Cell RNASeq profiling of stromal vascular fraction from Subcutaneous and visceral adipose tissue 0.84
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [Toxin] 0.83
Conservative alteration of chromosomal expression pattern across human solid tumor types 0.83
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 0.82
Next Generation Sequencing upon siRNA-mediated knockdown of DRAIC in MCF-7 cells. 0.81
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG [RNA-seq] 0.81
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG 0.81
A Stable Transcription Factor Complex Nucleated by Dimeric AML1-ETO Controls Leukaemogenesis 0.8
Effect of venetoclax, tedizolid, and combination treatment on gene expression in a venetoclax-resistant AML cell line 0.79
Characterization of EZH2-deficient human embryonic stem cells [ChIP-seq and bulk RNA-seq] 0.77
The effect of Abl kinases on non-small cell carcinoma global transcriptome 0.77
Transcriptional response of human endocervical epithelial A2EN cells to infection with wild-type or CpoS-deficient Chlamydia trachomatis L2/434/Bu 0.77
Human muscle-derived CLEC14A-positive cells regenerate muscle independent of PAX7 0.74
Genome-wide DNA hypomethylation and RNA:DNA hybrid accumulation in Aicardi-Goutières syndrome 0.74
Extracellular matrix (ECM) stiffness and collagen-1 (col-1) responsive genes in 3D cultured mammary epithelial cells 0.72
Expression profiling of MCF-7 cells with 10nM treatment of TCDD 0.72
Expression profiling of MCF-7 cells with treatment of TCDD 0.72
Anti-Inflammatory Effects of Budesonide in Human Fetal Lung 0.72
BRG1 governs Glucocorticoid Receptor interactions with chromatin and pioneer factors across the genome 0.69
Defining the Transcriptional Landscape during Cytomegalovirus Latency with Single-Cell RNA Sequencing 0.67
Genome-wide expression from the esophageal biopsies of subjects with and without eosinophilic esophagitis 0.66
Single-cell survey of human lymphatics unveils marked endothelial cell heterogeneity and mechanisms of homing for neutrophils 0.66
Differential effects of estrogen receptor beta isoforms on glioblastoma progression 0.59
Messenger RNA expression after silencing or inhibition of MEN1in MCF-7 breast cancer cells 0.56
A specific missense mutation in GTF2I occurs at high frequency in thymic epithelial tumors 0.56
Profiling of protrusion-enriched RNAs from human breast cancer cell line MDA-MB-231 0.55
Single-cell Transcriptomics reveals multi-step adaptations to endocrine therapy 0.53
Activating Transcription Factor 4 modulated TGFb-induced aggresiveness in triple negative breast cancer vis SMAD2/3/4 and mTORC2 signaling 0.53
A20 regulates canonical wnt-signaling through an interaction with RIPK4 0.51
KRASG12C inhibition produces a driver-limited state revealing collateral dependencies 0.5
DDX54 regulates transcriptome dynamics during DNA damage response [4SU-seq] 0.49
Dexamethasone inhibits respiratory syncytial virus-driven mucus production while increasing viral replication without altering antiviral interferon signaling 0.48
Influenza Vaccination Primes Human Myeloid Cell Cytokine Secretion and Natural Killer Cell Function 0.48
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 0.47
Club cells surviving influenza A virus infection induce temporary non-specific anti-viral immunity 0.41
Study of dynamic transcriptome profiling in DNA damage-induced cellular senescence and transient cell-cycle arrest 0.4
MULTI-seq: Universal sample multiplexing for single-cell RNA sequencing using lipid-tagged indices 0.4
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [TAV] 0.4
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 [RNA-Seq] 0.39
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 0.39
RNA-Seq and expression data from human adipose tissue 0.38
Tissue-specific RNA-seq in human evoked inflammation identifies novel blood and adipose lincRNA signatures of cardio-metabolic diseases 0.38
Altered mRNA splicing by mutant p53 activates oncogenic RAS in pancreatic cancer 0.38
HIV Reprograms Human Airway Basal Stem/Progenitor Cells to Acquire a Tissue Destructive Phenotype 0.37
Identification of grade and origin specific cell populations in serous epithelial ovarian cancer by single cell RNA-seq 0.37
Gene Expression Signature in Adipose Tissue of Acromegaly Patients 0.36
Identification of atheroprone shear stress responsive regulatory elements in endothelial cells 0.31
Gene expression profile of calcified and normal tricuspid aortic valves by RNA sequencing. 0.3
The transcriptome of Kawasaki Disease arteritis 0.29
Transcriptome-analysis of patient-derived normal and ulcerative colitis intestinal epithelial organoids 0.29
Modulation of ESRP2 and MBNL2 in normal kidney and clear cell renal cell carcinoma cell lines for analysis of stability programs 0.29
Role of OSGIN1 in Mediating Smoking-induced Autophagy in the Human Airway Epithelium 0.27
Role of OSGIN1 in Mediating Smoking-induced Autophagy in the Human Airway Epithelium [RNA-Seq] 0.27
Research resource: global identification of estrogen receptor β target genes in triple negative breast cancer cells 0.25
Illumina Human Polycystic Liver Disease and Normal Biliary Stem Cell RNAseq 0.25
Smoking Dysregulates the Human Airway Basal Cell Transcriptome at COPD-linked Risk Locus 19q13.2 0.25
Electronic cigarettes 0.24
Does osteogenic potential of clonal human bone marrow mesenchymal stem/stromal cells correlate with their vascular supportive ability? 0.24
Apoptosis enhancing drugs overcome innate platinum resistance in CA125 negative tumor initiating populations of high grade serous ovarian cancer 0.23
Fusion discovery in breast cancer cell line 0.22
Neonatal and adult human testis defined at the single-cell level 0.2
RNAseq of cell lines with knocked in ESR1 mutations 0.18
The transcriptome of human endometrial mesenchymal stem cells under TGFβR inhibition reveals improved potential for cell-based therapies 0.15
Differential gene expressions in the heart of hypertrophic cardiomyopathy patients 0.13
Codon usage optimization in pluripotent embryonic stem cells [tRNA sequencing] 0.13
Expression profile of GIST48 cells with siETV1 or siFOXF1 knockdown 0.12
FOXF1 defines the core-regulatory circuitry in gastrointestinal stromal tumor (GIST) 0.12
Genome-wide expression analysis of human hTert immortalized fibroblasts after downregulation of MCM2 & MCM7 0.12
Toxoplasma gondii remodels the cis-regulatory landscape of infected human host cells [RNA-seq] 0.11
Toxoplasma gondii remodels the cis-regulatory landscape of infected human host cells 0.11
Toxoplasma controls host cyclin E expression through the use of a novel MYR1-dependent effector protein, HCE1 0.11
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk 0.1
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk [RNA-seq] 0.1
Preclinical model of obesity and ER-positive breast cancer 0.08
Osmostress induced changes of chromatin architecture and transcription in mammalian cells 0.08
Osmostress induced changes of chromatin architecture and transcription in mammalian cells [RNA-Seq, HiC] 0.08
Hyperactive mTOR and MNK1 phosphorylation of eIF4E confer tamoxifen resistance and estrogen independence through selective mRNA translation reprogramming 0.08
Selective silencing of euchromatic L1s revealed by genome-wide screens for L1 regulators 0.07
An Open-Label Pilot Study to Evaluate the Efficacy of Tofacitinib in Moderate to Severe Patch Type Alopecia Areata, Totalis and Universalis 0.07
An interaction with Ewing's sarcoma breakpoint protein EWS defines the specific oncogenic mechanism of ETS factors rearranged in prostate cancer 0.07
rG4-seq reveals widespread formation of G-quadruplex structures in the human transcriptome 0.06
Impact of Escherichia coli K12 and O18 on human platelets: effects on platelet activation, spliced platelet RNAs and proteins 0.05
RNA seq analysis of human Fetal and adult derived Enterospheres 0.05
SOX11 knockdown in B-ALL cell lines 0.02
Next Generation Sequencing upon siRNA-mediated knockdown of EIF5A in MCF-7 cells. 0.01
RNA-Seq data for five HER2 over-expressed samples with twelve green fluorescent protein control samples using human mammary epithelial cells 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation